These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 23157793)
1. Febrile ulceronecrotic Mucha-Habermann disease: a case with systemic symptoms managed with subcutaneous methotrexate. Lin CY; Cook J; Purvis D Australas J Dermatol; 2012 Nov; 53(4):e83-6. PubMed ID: 23157793 [TBL] [Abstract][Full Text] [Related]
2. Febrile ulceronecrotic Mucha-Habermann disease in an 8-year-old boy responding to methotrexate. Alratrout J; Alshammasi F; Ansari N Int J Dermatol; 2016 Nov; 55(11):1205-1209. PubMed ID: 27368714 [TBL] [Abstract][Full Text] [Related]
3. Febrile ulceronecrotic Mucha-Habermann disease: treatment with infliximab and intravenous immunoglobulins and review of the literature. Meziane L; Caudron A; Dhaille F; Jourdan M; Dadban A; Lok C; Chaby G Dermatology; 2012; 225(4):344-8. PubMed ID: 23391565 [TBL] [Abstract][Full Text] [Related]
4. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature. Suárez J; López B; Villalba R; Perera A Dermatology; 1996; 192(3):277-9. PubMed ID: 8726649 [TBL] [Abstract][Full Text] [Related]
5. Febrile Ulceronecrotic Mucha-Habermann Disease: A Case Report and Review of Literature in the Paediatric Population. Liu J; Zhong J; Wang Q; Cai Y; Chen J Acta Derm Venereol; 2023 Apr; 103():adv4806. PubMed ID: 37073962 [TBL] [Abstract][Full Text] [Related]
6. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature. Sotiriou E; Patsatsi A; Tsorova C; Lazaridou E; Sotiriadis D Acta Derm Venereol; 2008; 88(4):350-5. PubMed ID: 18709304 [TBL] [Abstract][Full Text] [Related]
7. Febrile ulceronecrotic Mucha-Habermann disease with central nervous system vasculitis. Rosman IS; Liang LC; Patil S; Bayliss SJ; White AJ Pediatr Dermatol; 2013; 30(1):90-3. PubMed ID: 22276640 [TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline and cyclosporine in the treatment of febrile ulceronecrotic Mucha-Habermann disease. Uzoma MA; Wilkerson MG; Carr VL; Westhoven GS; Raimer SA Pediatr Dermatol; 2014; 31(4):525-7. PubMed ID: 23005254 [TBL] [Abstract][Full Text] [Related]
14. Febrile ulceronecrotic Mucha-Habermann disease in adult patient successfully treated with systemic corticosteroid. Nassif PW; Godoy DA; Nakandakari S; Alves CJ; Soares CT An Bras Dermatol; 2010; 85(6):891-4. PubMed ID: 21308316 [TBL] [Abstract][Full Text] [Related]
15. Febrile Ulceronecrotic Mucha-Habermann Disease: Two Cases with Excellent Response to Methotrexate. Griffith-Bauer K; Leitenberger SL; Krol A Pediatr Dermatol; 2015; 32(6):e307-8. PubMed ID: 26584702 [TBL] [Abstract][Full Text] [Related]
16. A case of febrile ulceronecrotic Mucha-Habermann disease with comorbidities. Bhide DS; Tulpule MS; Pethe SV Indian J Dermatol Venereol Leprol; 2019; 85(6):660-663. PubMed ID: 30860167 [TBL] [Abstract][Full Text] [Related]
17. A case of febrile ulceronecrotic Mucha-Habermann disease responsive to systemic corticosteroids. Rai E; Kamzan A; Boozalis E; Hogeling M; Fong K Pediatr Dermatol; 2023; 40(3):573-575. PubMed ID: 36573550 [TBL] [Abstract][Full Text] [Related]